- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06183580
Teen Brain Training (TBT)
Neurofeedback and Neural Plasticity of Self-Processing and Affect Regulation Circuits in Suicide Attempting Adolescents
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55414
- University of Minnesota
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adolescents with a history of suicide attempts
Exclusion Criteria:
- Psychotic disorders.
- Primary substance use disorder.
- Primary anorexic disorder.
- Autism Spectrum Disorder.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: dACC Arm
Participants assigned to the Neurofeedback from the dorsal anterior cingulate cortex
|
Participants are pseudorandomized to the dACC group to undergo neurofeedback (NF).
NF training consists of four ~7.33 min NF training runs preceded by a 5 min baseline (no NF) and followed by a 5 min transfer run (no NF).
Training entails NF blocks paired to a self-happy face along a bar that indicates changing levels of the dACC.
During the control condition, participants will count backward (CB) from 100 cued by an unfamiliar happy face with no NF.
During rest conditions, participants see the cue "Rest" and are asked to relax with their eyes open.
During NF, participants will try to increase dACC neural activity by recalling happy memories.
The colored bar indicating the neural activity will shift up or down depending on values provided by Turbo-BrainVoyager software.
Green = Activity > baseline and red = Activity < baseline.
Before and after NF training, suicide ideation severity, depression severity, and performance on self-processing behavioral tasks will be assessed.
|
|
Experimental: rAMY Arm
Participants assigned to the Neurofeedback from the amygdala
|
Participants are pseudorandomized to the rAMY group to undergo neurofeedback (NF).
NF training consists of four ~7.33 min NF training runs preceded by a 5 min baseline (no NF) and followed by a 5 min transfer run (no NF).
Training entails NF blocks paired to a self-happy face along a bar that indicates changing levels of the rAMY.
During the control condition, participants will count backward (CB) from 100 cued by an unfamiliar happy face with no NF.
During rest conditions, participants see the cue "Rest" and are asked to relax with their eyes open.
During NF, participants will try to increase rAMY neural activity by recalling happy memories.
The colored bar indicating the neural activity will shift up or down depending on values provided by Turbo-BrainVoyager software.
Green = Activity > baseline and red = Activity < baseline.
Before and after NF training, suicide ideation severity, depression severity, and performance on self-processing behavioral tasks will be assessed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Columbia Suicide Severity Rating Scale (CSSRS) - Visit 1
Time Frame: Day 0
|
The CSSRS has a scale 0-5 with 0 indicating no suicide ideation and 5 indicating suicide ideation with intent and plan. Higher values are considered the worst outcome The units are ordinal units scored by a clinician following the descriptions in the instrument. Suicidal Ideation Severity Subscale: This core scale has a range of 0 to 5. 0 = No suicidal ideation
|
Day 0
|
|
Columbia Suicide Severity Rating Scale (CSSRS) - Visit 4
Time Frame: Week 11
|
The CSSRS has a scale 0-5 with 0 indicating no suicide ideation and 5 indicating suicide ideation with intent and plan. Higher values are considered the worst outcome The units are ordinal units scored by a clinician following the descriptions in the instrument. Suicidal Ideation Severity Subscale: This core scale has a range of 0 to 5. 0 = No suicidal ideation
|
Week 11
|
|
Columbia Suicide Severity Rating Scale (CSSRS) - Visit 5
Time Frame: Week 16
|
The CSSRS has a scale 0-5 with 0 indicating no suicide ideation and 5 indicating suicide ideation with intent and plan. Higher values are considered the worst outcome The units are ordinal units scored by a clinician following the descriptions in the instrument. Suicidal Ideation Severity Subscale: This core scale has a range of 0 to 5. 0 = No suicidal ideation
|
Week 16
|
|
Suicide Ideation Questionnaire (SIQ) - Visit 1
Time Frame: Day 0
|
Total Suicide Ideation.
The suicide ideation questionnaire is a self report measure, higher values indicatemore severe suicide ideation.
The total score can range between a minimum of 0 to a maximum 180 (for the 30-item version).
A sum of 41 or higher is a common cut-off score indicating the need for further evaluation.
Higher scores mean a worse outcome
|
Day 0
|
|
Suicide Ideation Questionnaire (SIQ) - Visit 4
Time Frame: Week 11
|
Total Suicide Ideation.
The suicide ideation questionnaire is a self report measure, higher values indicatemore severe suicide ideation.
The total score can range between a minimum of 0 to a maximum 180 (for the 30-item version).
A sum of 41 or higher is a common cut-off score indicating the need for further evaluation.
Higher scores mean a worse outcome
|
Week 11
|
|
Suicide Ideation Questionnaire (SIQ) - Visit 5
Time Frame: Week 16
|
Total Suicide Ideation.
The suicide ideation questionnaire is a self report measure, higher values indicatemore severe suicide ideation.
The total score can range between a minimum of 0 to a maximum 180 (for the 30-item version).
A sum of 41 or higher is a common cut-off score indicating the need for further evaluation.
Higher scores mean a worse outcome
|
Week 16
|
|
Neural Target Engagement - Visit 2
Time Frame: Week 5
|
Activity for the Neural Target indicates level of blood oxigen level dependent activity as obtained via functional magnetic resonance imaging.
Higher levels indicate more activity in the area of interest compared to baseline states of the brain.
|
Week 5
|
|
Neural Target Engagement - Visit 3
Time Frame: Week 8
|
Activity for the Neural Target indicates level of blood oxigen level dependent activity as obtained via functional magnetic resonance imaging.
Higher levels indicate more activity in the area of interest compared to baseline states of the brain.
|
Week 8
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difficulties in Emotion Regulation (DERS) - Visit 1
Time Frame: Day 0
|
The Difficulties in Emotion Regulation scale is a self-report questionnaire that measures difficulties with emotion regulation.
To score the DERS in this study we scored each of the emotion dysregulation scales separately by addidng the items that comprised each scale and dividing the total by the number of items.
The total DERS score was calculated by the following formula: COMPUTE ders_average=MEAN(ders_difficultygoal_score,ders_impulsecontrol_score, ders_lackemoclarity_score,ders_limaccesstoer_score,ders_lowemoaware_score, ders_nonacceptance_score). Higher values indicate more difficulties with emotion regulation.
It has a total score range of 9 to 25.33 for the full 36-item version, where higher scores indicate greater difficulty with emotion regulation.
|
Day 0
|
|
Difficulties in Emotion Regulation (DERS) - Visit 2
Time Frame: Week 5
|
The Difficulties in Emotion Regulation scale is a self-report questionnaire that measures difficulties with emotion regulation.
To score the DERS in this study we scored each of the emotion dysregulation scales separately by addidng the items that comprised each scale and dividing the total by the number of items.
The total DERS score was calculated by the following formula: COMPUTE ders_average=MEAN(ders_difficultygoal_score,ders_impulsecontrol_score, ders_lackemoclarity_score,ders_limaccesstoer_score,ders_lowemoaware_score, ders_nonacceptance_score). Higher values indicate more difficulties with emotion regulation.
It has a total score range of 9 to 25.33 for the full 36-item version, where higher scores indicate greater difficulty with emotion regulation.
|
Week 5
|
|
Difficulties in Emotion Regulation (DERS) - Visit 3
Time Frame: Week 8
|
The Difficulties in Emotion Regulation scale is a self-report questionnaire that measures difficulties with emotion regulation.
To score the DERS in this study we scored each of the emotion dysregulation scales separately by addidng the items that comprised each scale and dividing the total by the number of items.
The total DERS score was calculated by the following formula: COMPUTE ders_average=MEAN(ders_difficultygoal_score,ders_impulsecontrol_score, ders_lackemoclarity_score,ders_limaccesstoer_score,ders_lowemoaware_score, ders_nonacceptance_score). Higher values indicate more difficulties with emotion regulation.
It has a total score range of 9 to 25.33 for the full 36-item version, where higher scores indicate greater difficulty with emotion regulation.
|
Week 8
|
|
Difficulties in Emotion Regulation (DERS) - Visit 4
Time Frame: Week 11
|
The Difficulties in Emotion Regulation scale is a self-report questionnaire that measures difficulties with emotion regulation.
To score the DERS in this study we scored each of the emotion dysregulation scales separately by addidng the items that comprised each scale and dividing the total by the number of items.
The total DERS score was calculated by the following formula: COMPUTE ders_average=MEAN(ders_difficultygoal_score,ders_impulsecontrol_score, ders_lackemoclarity_score,ders_limaccesstoer_score,ders_lowemoaware_score, ders_nonacceptance_score). Higher values indicate more difficulties with emotion regulation.
It has a total score range of 9 to 25.33 for the full 36-item version, where higher scores indicate greater difficulty with emotion regulation.
|
Week 11
|
|
Difficulties in Emotion Regulation (DERS) - Visit 5
Time Frame: Week 16
|
The Difficulties in Emotion Regulation scale is a self-report questionnaire that measures difficulties with emotion regulation.
To score the DERS in this study we scored each of the emotion dysregulation scales separately by addidng the items that comprised each scale and dividing the total by the number of items.
The total DERS score was calculated by the following formula: COMPUTE ders_average=MEAN(ders_difficultygoal_score,ders_impulsecontrol_score, ders_lackemoclarity_score,ders_limaccesstoer_score,ders_lowemoaware_score, ders_nonacceptance_score). Higher values indicate more difficulties with emotion regulation.
It has a total score range of 9 to 25.33 for the full 36-item version, where higher scores indicate greater difficulty with emotion regulation.
|
Week 16
|
|
Responses to Depression (RD) - Visit 1
Time Frame: Day 0
|
This questionnaire measures the tendencies to dwell or ruminate about one's symptoms and depression.
Higher scores indicate more difficulties with rumination.
The score range is 22 to 88, with a total score calculated by summing the responses to its 22 items.
Higher scores indicate a greater tendency to respond to sadness with rumination, which can include self-analysis, dwelling on one's anger, or brooding.
|
Day 0
|
|
Responses to Depression (RD) - Visit 2
Time Frame: Week 5
|
This questionnaire measures the tendencies to dwell or ruminate about one's symptoms and depression.
Higher scores indicate more difficulties with rumination.
The score range is 22 to 88, with a total score calculated by summing the responses to its 22 items.
Higher scores indicate a greater tendency to respond to sadness with rumination, which can include self-analysis, dwelling on one's anger, or brooding.
|
Week 5
|
|
Responses to Depression (RD) - Visit 3
Time Frame: Week 8
|
This questionnaire measures the tendencies to dwell or ruminate about one's symptoms and depression.
Higher scores indicate more difficulties with rumination.
The score range is 22 to 88, with a total score calculated by summing the responses to its 22 items.
Higher scores indicate a greater tendency to respond to sadness with rumination, which can include self-analysis, dwelling on one's anger, or brooding.
|
Week 8
|
|
Responses to Depression (RD) - Visit 4
Time Frame: Week 11
|
This questionnaire measures the tendencies to dwell or ruminate about one's symptoms and depression.
Higher scores indicate more difficulties with rumination.
The score range is 22 to 88, with a total score calculated by summing the responses to its 22 items.
Higher scores indicate a greater tendency to respond to sadness with rumination, which can include self-analysis, dwelling on one's anger, or brooding.
|
Week 11
|
|
Responses to Depression (RD) - Visit 5
Time Frame: Week 16
|
This questionnaire measures the tendencies to dwell or ruminate about one's symptoms and depression.
Higher scores indicate more difficulties with rumination.
The score range is 22 to 88, with a total score calculated by summing the responses to its 22 items.
Higher scores indicate a greater tendency to respond to sadness with rumination, which can include self-analysis, dwelling on one's anger, or brooding.
|
Week 16
|
|
Children's Depression Rating Scale - Visit 1
Time Frame: Day 0
|
For the Children's Depression Rating Scale-Revised (CDRS-R), which is clinician-rated, the total score ranges from 17 to 113.
Higher values indicate a higher severity of child depression.
Remission (minimal/no symptoms): <=28.
Moderate to Severe Depression>=40.
|
Day 0
|
|
Children's Depression Rating Scale - Visit 4
Time Frame: Week 11
|
For the Children's Depression Rating Scale-Revised (CDRS-R), which is clinician-rated, the total score ranges from 17 to 113.
Higher values indicate a higher severity of child depression.
Remission (minimal/no symptoms): <=28.
Moderate to Severe Depression>=40.
|
Week 11
|
|
Children's Depression Rating Scale - Visit 5
Time Frame: Week 16
|
For the Children's Depression Rating Scale-Revised (CDRS-R), which is clinician-rated, the total score ranges from 17 to 113.
Higher values indicate a higher severity of child depression.
Remission (minimal/no symptoms): <=28.
Moderate to Severe Depression>=40.
|
Week 16
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Karina Quevedo, University of Minnesota
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PSYCH-2020-29400
- 1R61MH122634-01 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on neurofeedback training involving dACC
-
University of HartfordCompleted
-
Chang Gung Memorial HospitalWithdrawnPost Operative Pain | Pain, Shoulder
-
Osaka UniversityJapan Agency for Medical Research and DevelopmentUnknown
-
Stanford UniversityCompleted
-
Leiden University Medical CenterCompletedElevated EEG Theta/Beta Ratio
-
Quietmind FoundationCompleted
-
University of FloridaNational Institute on Aging (NIA)RecruitingCognitive Change | Aging | Neurocognitive Disorders, MildUnited States
-
East Kent Hospitals University NHS Foundation TrustExsurgo LtdCompleted
-
NHS Greater Glasgow and ClydeCompleted
-
Frank ScharnowskiUnknown